Home / KEEP BUT DO NOT DISPLAY / Alerts / ADA/EASD Issue New Management Guidelines and FDA Rejects Diabetes Drug Alogliptin

ADA/EASD Issue New Management Guidelines and FDA Rejects Diabetes Drug Alogliptin

Apr 27, 2012
1,953 views
 

ADA/EASD Issue New Management Guidelines (see this week’s Item #2) and FDA Rejects Diabetes Drug Alogliptin (see this week’s Item #10).